3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Rasmussen subacute encephalitis
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Plasmablastic Lymphoma
1
Opsoclonus-Myoclonus Syndrome
1
Neuromyelitis Optica
1
Myasthenia Gravis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lambert-Eaton Myasthenic Syndrome
1
Hodgkin Disease
1
HIV Infections
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Autoimmune Diseases
1
Interventions
Temozolomide
43
Magnetic Resonance Spectroscopy
41
Radiotherapy
23
Specimen Handling
18
Biopsy
13
X-Rays
10
Radiation
10
trametinib
8
Bevacizumab
8
Nivolumab
7
Blood Specimen Collection
7
olaparib
6
fluorodopa F 18
6
dabrafenib
6
Radiotherapy, Intensity-Modulated
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
pembrolizumab
5
abemaciclib
5
Standard of Care
5
Lomustine
5
ulixertinib
4
larotrectinib
4
ivosidenib
4
erdafitinib
4
Surgical Procedures, Operative
4
Dianhydrogalactitol
4
Cyclophosphamide
4
Aminolevulinic Acid
4
vorasidenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
carmustine, poliferprosan 20 drug combination
×
1 year
×
Clear all
No trials found.